These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

599 related items for PubMed ID: 19744598

  • 1. Nephrogenic systemic fibrosis: clinical picture and treatment.
    Marckmann P, Skov L.
    Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
    [Abstract] [Full Text] [Related]

  • 2. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J.
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [Abstract] [Full Text] [Related]

  • 3. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
    Prince MR, Zhang HL, Prowda JC, Grossman ME, Silvers DN.
    Radiographics; 2009 Oct; 29(6):1565-74. PubMed ID: 19959508
    [Abstract] [Full Text] [Related]

  • 4. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
    Kribben A, Witzke O, Hillen U, Barkhausen J, Daul AE, Erbel R.
    J Am Coll Cardiol; 2009 May 05; 53(18):1621-8. PubMed ID: 19406336
    [Abstract] [Full Text] [Related]

  • 5. Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.
    Bernstein EJ, Schmidt-Lauber C, Kay J.
    Best Pract Res Clin Rheumatol; 2012 Aug 05; 26(4):489-503. PubMed ID: 23040363
    [Abstract] [Full Text] [Related]

  • 6. [Nephrogenic systemic fibrosis--new clinical entity].
    Prvulović M.
    Med Pregl; 2008 Aug 05; 61(9-10):439-41. PubMed ID: 19203058
    [Abstract] [Full Text] [Related]

  • 7. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 8. Gadolinium and nephrogenic systemic fibrosis: have we overreacted?
    Penfield JG, Reilly RF.
    Semin Dial; 2011 Oct 01; 24(5):480-6. PubMed ID: 21913988
    [Abstract] [Full Text] [Related]

  • 9. Nephrogenic systemic fibrosis: clinical spectrum of disease.
    Mayr M, Burkhalter F, Bongartz G.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1289-97. PubMed ID: 19937929
    [Abstract] [Full Text] [Related]

  • 10. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
    Boyd AS, Sanyal S, Abraham JL.
    J Am Acad Dermatol; 2010 Feb 01; 62(2):337-42. PubMed ID: 19939504
    [Abstract] [Full Text] [Related]

  • 11. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
    Weinreb JC, Abu-Alfa AK.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1236-9. PubMed ID: 19938035
    [Abstract] [Full Text] [Related]

  • 12. Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.
    Idée JM, Port M, Dencausse A, Lancelot E, Corot C.
    Radiol Clin North Am; 2009 Sep 01; 47(5):855-69, vii. PubMed ID: 19744600
    [Abstract] [Full Text] [Related]

  • 13. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
    Wilford C, Fine JD, Boyd AS, Sanyal S, Abraham JL, Kantrow SM.
    Am J Dermatopathol; 2010 Feb 01; 32(1):71-5. PubMed ID: 19940755
    [Abstract] [Full Text] [Related]

  • 14. Current status of nephrogenic systemic fibrosis.
    Daftari Besheli L, Aran S, Shaqdan K, Kay J, Abujudeh H.
    Clin Radiol; 2014 Jul 01; 69(7):661-8. PubMed ID: 24582176
    [Abstract] [Full Text] [Related]

  • 15. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
    Wiedemeyer K, Kutzner H, Abraham JL, Thakral C, Carlson JA, Tran TA, Hausser I, Hartschuh W.
    Am J Dermatopathol; 2009 Oct 01; 31(7):674-81. PubMed ID: 19633532
    [Abstract] [Full Text] [Related]

  • 16. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
    Panesar M, Boateng F, Patel SS, Masood SF, Mahajan P, Patel N, Murray B.
    Hemodial Int; 2010 Jul 01; 14(3):289-94. PubMed ID: 20662951
    [Abstract] [Full Text] [Related]

  • 17. Application of gadolinium-based contrast agents and prevalence of nephrogenic systemic fibrosis in a cohort of end-stage renal disease patients on hemodialysis.
    Becker S, Walter S, Witzke O, Kreuter A, Kribben A, Mitchell A.
    Nephron Clin Pract; 2012 Jul 01; 121(1-2):c91-4. PubMed ID: 23182840
    [Abstract] [Full Text] [Related]

  • 18. Nephrogenic systemic fibrosis: histology and gadolinium detection.
    Thakral C, Abraham JL.
    Radiol Clin North Am; 2009 Sep 01; 47(5):841-53, vi-vii. PubMed ID: 19744599
    [Abstract] [Full Text] [Related]

  • 19. Nephrogenic systemic fibrosis: a review of the new conundrum.
    Goenka AH, Das CJ, Sharma R.
    Natl Med J India; 2009 Sep 01; 22(6):302-6. PubMed ID: 20384019
    [Abstract] [Full Text] [Related]

  • 20. How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States.
    Thomsen HS.
    Radiol Clin North Am; 2009 Sep 01; 47(5):871-5, vii. PubMed ID: 19744601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.